0.919

3.68% -0.031

China Pharma Holdings Inc. (CPHI)

Overview News Price History Discussions Forecast Stock Split

China Pharma Holdings Inc. stock is traded at $0.919, with a volume of 101.52K. It is down -3.68% in the last 24 hours and down -39.80% over the past month. China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.

Previous Close:

$0.95

Open:

$0.9574

24h Volume:

101.52K

Relative Volume:

0.03

Market Cap:

$39.37M

Revenue:

$3.99M

Net Income/Loss:

$-3.55M

P/E Ratio:

-1.6682

EPS:

-0.5509

Net Cash Flow:

$94,500

1W Performance:

-15.28%

1M Performance:

-39.80%

6M Performance:

+64.01%

1Y Performance:

-35.56%

1-Day Range:

$0.90

$0.96

1-Week Range:

$0.90

$1.0887

52-Week Range:

$0.3818

$19.19

China Pharma Holdings Inc. Stock (CPHI) Company Profile

Name

China Pharma Holdings Inc.

Sector

Healthcare (1083)

Industry

Drug Manufacturers - Specialty & Generic (79)

Phone

86 898 6681 1730

Address

No. 17, Jinpan Road, Second Floor, Haikou

Employee

276

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

CPHI's Discussions on Twitter

Compare CPHI vs TAK, HLN, TEVA, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CPHI China Pharma Holdings Inc.	0.915	45.60M	3.99M	-3.55M	94,500	-0.5509
TAK Takeda Pharmaceutical Co Adr	18.30	57.90B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	10.15	43.41B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	37.56	42.89B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	76.83	31.00B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	517.92	22.35B	3.17B	1.29B	1.01B	27.09

China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-08-10	Initiated	Rodman & Renshaw	Mkt Outperform

China Pharma Holdings Inc. Stock (CPHI) Latest News

Aug 20, 2026

China (CPHI) Earnings Snapshot: EPS Does Not Reach the Reported Estimate in the Latest Reading; Price Move: Shares Close 3.70% Lower in Latest TradingEstimate Uncertainty - vinanet.vn

Aug 20, 2026

Aug 18, 2026

China (CPHI) Session Check: Closes Nearly Flat at $1.08 in Latest Trading; Boundary Check: the Supplied Trading Band Runs From $1.03 to $1.13 under the Current SnapshotSign of Weakness - Vinanet

Aug 18, 2026

Aug 17, 2026

China Pharma Holdings (CPHI) Edges Higher as Stock Holds Above $1.08 SupportSpring Pattern - vinanet.vn

Aug 17, 2026

Aug 16, 2026

China Pharma Holdings (CPHI) Gains 3.67% to $1.13, Approaches Key Resistance at $1.19High Conviction Picks - dars.gov.et

Aug 16, 2026

Aug 15, 2026

CPHI Q3 2011 Earnings: EPS Misses Estimates by 34.64% as Shares Rise 3.67%Earnings Acceleration Picks - vinanet.vn

Aug 15, 2026

China Pharma (CPHI) - Moomoo

Aug 15, 2026

Oral Antibiotic Medications Market to Reach 135-150 Index by 2035 on Rising Outpatient Prescriptions - IndexBox

Aug 15, 2026

Aug 14, 2026

China Pharma Holdings (CPHI) posts larger loss but raises cash and adds patents - Stock Titan

Aug 14, 2026

China Pharma Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 14, 2026

Aug 13, 2026

CPHI Stock Craters As $5M Offering Fuels Extreme Volatility - timothysykes.com

Aug 13, 2026

Aug 12, 2026